Literature DB >> 7732656

Japanese encephalitis virus nonstructural protein NS3 has RNA binding and ATPase activities.

T Takegami1, D Sakamuro, T Furukawa.   

Abstract

Sequence data suggest that Japanese encephalitis virus (JEV) protein NS3 is a multifunctional protein with sequence motifs characteristic of a protease and a helicase. To examine the functions of JEV-NS3, a fusion protein of NS3 in Escherichia coli was generated. Analysis by Western blot using monospecific rabbit antisera generated against the fusion protein (anti-MBJEN3) showed that NS3 was localized in the membrane fraction of JEV-infected cells and the particulate fraction of bacteria extracts. The addition of anti-MBJEN3 sera reduced JEV-specific RNA synthesis activity in a in vitro system. In addition, NS3 was shown to exhibit RNA binding and ATPase activities, suggesting this protein has an important role in viral RNA replication in virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732656     DOI: 10.1007/bf01702653

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  22 in total

1.  The carboxy-terminal part of the NS 3 protein of the West Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase.

Authors:  G Wengler; G Wengler
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

2.  Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses.

Authors:  J F Bazan; R J Fletterick
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

3.  Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication.

Authors:  P W Chu; E G Westaway
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

4.  Involvement of the host cell nuclear envelope membranes in the replication of Japanese encephalitis virus.

Authors:  E Zebovitz; J K Leong; S C Doughty
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Localization and functions of Japanese encephalitis virus nonstructural proteins NS3 and NS5 for viral RNA synthesis in the infected cells.

Authors:  Z Edward; T Takegami
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

8.  RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria.

Authors:  P Warrener; J K Tamura; M S Collett
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  Synthesis and localization of Japanese encephalitis virus RNAs in the infected cells.

Authors:  T Takegami; S Hotta
Journal:  Microbiol Immunol       Date:  1990       Impact factor: 1.955

10.  Characterization of Kunjin virus RNA-dependent RNA polymerase: reinitiation of synthesis in vitro.

Authors:  P W Chu; E G Westaway
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

View more
  18 in total

1.  Langat flavivirus protease NS3 binds caspase-8 and induces apoptosis.

Authors:  Grigori G Prikhod'ko; Elena A Prikhod'ko; Alexander G Pletnev; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly.

Authors:  Wen Jun Liu; Petra L Sedlak; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Suramin inhibits the in vitro expression of encephalitis B virus proteins NS3 and E.

Authors:  Keshu Xu; Hongyu Ren; Jianwen Zhu; Yun Yang; Fang Liao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

4.  Preliminary crystallographic characterization of an RNA helicase from Kunjin virus.

Authors:  Eloise Mastrangelo; Michela Bollati; Mario Milani; Nadège Brisbarre; Xavier de Lamballerie; Bruno Coutard; Bruno Canard; Alexander Khromykh; Martino Bolognesi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-11

5.  Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication.

Authors:  Jeffrey E McLean; Aleksandra Wudzinska; Emmanuel Datan; Daniela Quaglino; Zahra Zakeri
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

6.  Mutagenesis of the NS3 protease of dengue virus type 2.

Authors:  R P Valle; B Falgout
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures.

Authors:  E G Westaway; J M Mackenzie; M T Kenney; M K Jones; A A Khromykh
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  The RNA helicase and nucleotide triphosphatase activities of the bovine viral diarrhea virus NS3 protein are essential for viral replication.

Authors:  B Gu; C Liu; J Lin-Goerke; D R Maley; L L Gutshall; C A Feltenberger; A M Del Vecchio
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 9.  Organization of the Flavivirus RNA replicase complex.

Authors:  Carolin Brand; Martin Bisaillon; Brian J Geiss
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-08-16       Impact factor: 9.957

10.  Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing.

Authors:  Jinhua Wu; Aloke Kumar Bera; Richard J Kuhn; Janet L Smith
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.